BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1835562)

  • 1. Hypnosis and the treatment of Huntington's disease.
    Witz M; Kahn S
    Am J Clin Hypn; 1991 Oct; 34(2):79-90. PubMed ID: 1835562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypnosis as an adjunctive treatment in Huntington's disease.
    Moldawsky RJ
    Am J Clin Hypn; 1984 Apr; 26(4):229-31. PubMed ID: 6237574
    [No Abstract]   [Full Text] [Related]  

  • 3. Huntington's disease.
    Anderson KE
    Handb Clin Neurol; 2011; 100():15-24. PubMed ID: 21496569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors contributing to institutionalization in patients with Huntington's disease.
    Rosenblatt A; Kumar BV; Margolis RL; Welsh CS; Ross CA
    Mov Disord; 2011 Aug; 26(9):1711-6. PubMed ID: 21538527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile Huntington's disease: a case report and literature review.
    Reyes Molón L; Yáñez Sáez RM; López-Ibor Alcocer MI
    Actas Esp Psiquiatr; 2010; 38(5):285-94. PubMed ID: 21117003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multidisciplinary approach to the management of Huntington's disease.
    Kallail KJ; Godfrey NE; Suter G; Anthimides L
    Kans Med; 1989 Nov; 90(11):309-11. PubMed ID: 2531813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington's disease.
    Kent A
    Nurs Stand; 2004 Apr 21-27; 18(32):45-51; quiz 52-3. PubMed ID: 15132037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease. Part 1: essential background and management.
    Aubeeluck A; Wilson E
    Br J Nurs; 2008 Feb 14-27; 17(3):146-51. PubMed ID: 18414253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular therapeutic strategies for Huntington's disease].
    Milewski M; Hoffman-Zacharska D; Ball J
    Postepy Biochem; 2015; 61(1):18-24. PubMed ID: 26281350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's disease. Part 2: treatment and management issues in juvenile HD.
    Aubeeluck A; Brewer H
    Br J Nurs; 2008 Feb 28-Mar 12; 17(4):260-3. PubMed ID: 18414272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using research to develop care for patients with Huntington's disease.
    Skirton H; Glendinning N
    Br J Nurs; 1997 Jan 23-Feb 12; 6(2):83-90. PubMed ID: 9116444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living with Huntington's disease: need for supportive care.
    Dawson S; Kristjanson LJ; Toye CM; Flett P
    Nurs Health Sci; 2004 Jun; 6(2):123-30. PubMed ID: 15130098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current perspectives in the treatment of Huntington's chorea].
    Kuran W
    Neurol Neurochir Pol; 2002; 36(4):757-65. PubMed ID: 12418139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's disease: pathogenesis, diagnosis and treatment.
    Purdon SE; Mohr E; Ilivitsky V; Jones BD
    J Psychiatry Neurosci; 1994 Nov; 19(5):359-67. PubMed ID: 7528535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal degeneration in striatal transplants and Huntington's disease: potential mechanisms and clinical implications.
    Cicchetti F; Soulet D; Freeman TB
    Brain; 2011 Mar; 134(Pt 3):641-52. PubMed ID: 21278084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative care management of a child with juvenile onset Huntington's disease.
    King N
    Int J Palliat Nurs; 2005 Jun; 11(6):278-83. PubMed ID: 16010224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's disease: modeling the gait disorder and proposing novel treatments.
    Banaie M; Sarbaz Y; Gharibzadeh S; Towhidkhah F
    J Theor Biol; 2008 Sep; 254(2):361-7. PubMed ID: 18621402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial.
    de Yebenes JG; Landwehrmeyer B; Squitieri F; Reilmann R; Rosser A; Barker RA; Saft C; Magnet MK; Sword A; Rembratt A; Tedroff J;
    Lancet Neurol; 2011 Dec; 10(12):1049-57. PubMed ID: 22071279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated multidisciplinary care for Huntington's disease. An outpatient department.
    Veenhuizen RB; Tibben A
    Brain Res Bull; 2009 Oct; 80(4-5):192-5. PubMed ID: 19576265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.